drug
JUV-161
updated 5mo agoby Juvena Therapeutics Inc
community read0 votes
🐶 often sniffed alongside
top 2all catalysts(1)
Trials studying JUV-161
News(1)
- Chutes & Ladders—Neumora shuffles leadership ahead of INDJoshua Pinto, Ph.D., has been appointed chief executive officer of Neumora Therapeutics, a clinical-stage biotech with obesity and neuro assets.fiercebiotech · 1mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that